A phase I dose-escalation study of intratumoral herpes simplex virus-1 mutant HSV1716 in pediatric/young adult patients with refractory non-central nervous system solid tumors.
Timothy P. Cripe
No relevant relationships to disclose
John M Racadio
No relevant relationships to disclose
Joe Conner
Employment or Leadership Position - Virttu Biologics
Alexander Towbin
No relevant relationships to disclose
Marianne M Brunner
No relevant relationships to disclose
Beth A Stockman
No relevant relationships to disclose
Mark Currier
No relevant relationships to disclose
James I. Geller
No relevant relationships to disclose